MarketInOut Stock Screener Log In | Sign Up
 

Laboratorios Farmaceuticos Rovi S.A.

BME • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 05/12/2026 17:35
Laboratorios Farmaceuticos Rovi S.A. stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBME
Market Capitalization3,214.75 mln
Float16.30 mln
Earnings Date05/08/2026

EPS

2.36
Solid

P / E

25.89
Elevated

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.43
Borderline

1-Year Forecast

82.30
Strong upside

Relative Strength

1 / 100
Severely lagging

Business Description

Founded in 1946 and based near Madrid, Laboratorios Farmacéuticos Rovi is a Spanish pharmaceutical company that sells a broad range of prescription and hospital medicines across Europe and beyond, covering areas such as heart health, pain management, diagnostics, and respiratory care. The company also manufactures products on behalf of other pharmaceutical firms, handling everything from sterile filling and packaging to the application of safety devices for injectable and solid medicines. Rovi operates as part of the Norbel Inversiones group.

Key Fundamentals

EPS2.36
P/E25.89
ROE14.56
RPS10.22
ROIC12.64
ROA10.10
Interest Cover51.94
EBITDA, mln140
EV / EBITDA23.16
EV / EBIT27.73
Revenue, mln523
EV / Revenue6.20

Financial Strength

Altman Z-Score10.71
Piotroski F-Score 6 / 9
Beneish M-Score-2.43
Price to Intrinsic Value1.89
Price to Lynch Fair Value1.91
Price to Graham Number2.59
1-Year Target Price82.30
Shiller PE Ratio28.65

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -23.53% 0 / 100   
1 Month -26.69% 1 / 100   
2 Months -16.13% 10 / 100   
6 Months 11.19% 60 / 100   
1 Year 18.2% 51 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us